Trial intelligence / Profile preview

Levetiracetam for inpatient treatment of alcohol withdrawal syndrome

2005-001486-33Phase 3Completed

Sponsor
Charité Campus Mitte, Klinik für Psychiatrie und Psychotherapie
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in alcohol withdrawal syndrome (AWS) comparing Levetiracetam with Placebo (2 arms). Started Jun 2005; status: completed.

02

Drugs

levetiracetam
03

Conditions

alcohol withdrawal syndrome (AWS)

Beyond the preview

Go deeper on 2005-001486-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001486-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call